stockrow
Saturday 7 November 2026
Export GOVX’s income statement to Excel — free account
GeoVax Labs Inc.
GOVX Healthcare Biotechnology
GeoVax Labs Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 million, down 37.1% from fiscal 2024.
- Revenue
- +183.4%
- EPS
- +88.9%
- Free cash flow
- +15.8%
Quarter to June 2026, against a year earlier
0.15
0.01
−6.25%
Follow GOVX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.16 | 0.56 | 1.59 | 2.75 | |
Current Ratio |
1.54 | 1.06 | 2.74 | 3.57 | |
Net Debt/EBITDA |
0.71 | 0.24 | 0.70 | 0.79 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.83 | 0.67 | 1.12 | 0.98 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.80) | (1.76) | (5.18) | (7.66) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.80) | (1.76) | (5.18) | (7.66) | |
Cash per Share |
0.69 | 0.63 | 3.22 | 6.17 | |
Shareholders Equity per Share |
0.39 | 0.25 | 3.99 | 6.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.39 | 0.25 | 3.99 | 6.05 | |
Free Cash Flow |
(3.66) | (3.54) | (4.96) | (6.21) | |
Working Capital |
1.46 | 0.14 | 3.38 | 4.69 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
1.29 | (0.06) | 2.80 | 4.69 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
1.83 | 1.92 | 1.32 | 1.56 | |
Average Assets |
5.00 | 6.91 | 7.25 | 8.92 | |
Average Common Equity |
2.29 | 4.20 | 4.44 | 6.71 |
Columns are period end dates · fundamentals updated 26 Oct 2026